Last Updated 1 July 2022.
7 Vaccines Approved for Use in Canada
-
Novavax
Nuvaxovid- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 38 countries
17 trials in 13 countries
-
Medicago
Covifenz- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
6 trials in 6 countries
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 86 countries
67 trials in 23 countries
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 146 countries
85 trials in 27 countries
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 111 countries
24 trials in 24 countries
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 140 countries
66 trials in 31 countries
-
Serum Institute of India
Covishield (Oxford/ AstraZeneca formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 49 countries
4 trials in 1 country
12 Vaccines in Clinical Trials in Canada
-
Novavax
Nuvaxovid- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 38 countries
17 trials in 13 countries
-
Medicago
Covifenz- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
6 trials in 6 countries
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 86 countries
67 trials in 23 countries
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 146 countries
85 trials in 27 countries
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 140 countries
66 trials in 31 countries
-
University of Saskatchewan
COVAC-2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
5 trials in 1 country
-
VBI Vaccines Inc
VBI-2902a- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Entos Pharmaceuticals Inc
Covigenix VAX-001- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Providence Therapeutics Holdings Inc.
PTX-COVID19-B- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 2 countries
-
University of Saskatchewan
COVAC-1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 2 countries
-
McMaster University
Ad5-triCoV/Mac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
McMaster University
ChAd-triCoV/Mac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country